Curanex Pharmaceuticals Inc
CURX
$0.31
$0.000.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 5.24M | 2.98M | 677.50K | -- | -- |
| Gross Profit | -5.24M | -2.98M | -677.50K | -- | -- |
| SG&A Expenses | 2.05M | 1.26M | 541.80K | 361.20K | 347.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.29M | 4.24M | 1.22M | 361.20K | 347.70K |
| Operating Income | -7.29M | -4.24M | -1.22M | -361.20K | -347.70K |
| Income Before Tax | -7.24M | -4.23M | -1.30M | -435.00K | -418.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.24 | -4.23 | -1.30 | -0.44 | -0.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.24M | -4.23M | -1.30M | -435.00K | -418.90K |
| EBIT | -7.29M | -4.24M | -1.22M | -361.20K | -347.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.26 | -0.15 | -0.05 | -0.05 | -0.07 |
| Normalized Basic EPS | -0.16 | -0.10 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.26 | -0.16 | -0.05 | -0.05 | -0.07 |
| Normalized Diluted EPS | -0.16 | -0.10 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 106.32M | 101.97M | 114.04M | 90.84M | 69.24M |
| Average Diluted Shares Outstanding | 106.32M | 101.97M | 114.04M | 90.84M | 69.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |